Despite failed trials, experts believe we'll have an Alzheimer's drug by 2025

The results of recent trials that tested much-anticipated Alzheimer's disease drugs dashed the hopes of patients with the debilitating condition. The most recent disappointment came from the large trial for solanezumab, by Eli Lilly, announced last month.

But experts across the field say hope is not lost. They believe we will have some form of drug against the disease by 2025, albeit most likely a pilot version that will need to be upgraded.

Source: http://www.cnn.com/2016/12/09/health/alzhe...